There is also Nicola Bedin, former pro tempore managing director of the San Raffaele hospital and current president of Snam, among the 11 under investigation for fraud
The financial police of Milan have brought to light a maxi drug scam in the Lombardy region for around 10 million euros. The long investigation ended with the entry in the register of suspects of eleven people
A drug scam to the Lombardy region for more than 10 million euros was discovered by the guard of 
finance of Milan at the end of an in-depth investigation coordinated by the local prosecutor: 11 people under investigation including the current president of Snam Nicola Bedin, then CEO of the San Raffaele hospital controlled by the San Donato group. The other suspects are directors and commercial managers of 8 pharmaceutical companies, a former head of the purchasing office and a former manager of the group's pharmacy services.
In the notice of conclusion of the investigation signed by the prosecutor Paolo Storari and notified by the gdf in these hours there are five pharmaceutical companies whose administrators and commercial managers are under investigation: these are 8 managers, 4 of whom at the material time were employees of Mylan spa , one from Abbvie, one from Novartis, one from Eli Lilly Italia and the last one from Bayer spa. The other names are that of Massimo Stefanato, at the time representative of the San Raffaele purchasing office and Mario Giacomo Cavallazzi at the time responsible for the pharmacy services of various hospitals of the San Donato Group which also controls the hospital which was founded by Don Verzè.
According to what has emerged so far from the investigations, the pharmaceutical companies would have sold drugs to 9 hospitals of the San Donato Group that the same Group, which compensated the 10 million to Pirellone last December 3, would have been reimbursed by the Region at full price by failing to indicate the discounts applied on the price (from 2 to 20 per cent) following informal agreements linked to the achievement of certain purchase volumes. For the affair, again in December, Stefanato and Cavallazzi ended up under house arrest
Corriere della Sera reports the following names:
The names also include that of Giovanni Carubi, former sales manager of Mylan Spa and Alessandro Correnti; also investigated Cinzia Falasco Volpin, pro tempore managing director of the company Mylan and Silvia Marangoni, with the position of sales manager of the pharmaceutical company Novartis. For Bayer, however, the commercial manager Lucia Francesca Garza was investigated; moreover Luigi Rizzuto, with the same assignment for Abbvie and Alberto Albanese, of Eli-Lilly Italia. According to the investigative hypothesis, the drugs were purchased at market price, but in the credit notes the actual cost declared was lower; the difference was the proceeds of the scam for which the subjects - according to the investigators - agreed, while the cost was downloaded to the Region's coffers.
Note: Fedaiisf is not responsible for direct or indirect damages resulting from writings, opinions, errors, omissions or alterations of the texts reported and/or of authors other than Fedaiisf itself
